As the demand for GLP-1 weight loss medications such as Ozempic, Wegovy, and Zepbound continues to skyrocket, new survey ...
Consequently, food companies are rushing to reformulate products for protein lovers. That’s a category that includes both people taking the powerful new class of obesity drugs known as GLP-1s, who are ...
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
18hon MSN
The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...
These super high-flying US stocks have soared 222%, 122%, and 150%, respectively, in 2025. Let's take a look why.
Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...
It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback